Filing Flows › Iovance Biotherapeutics (IOVA) › Guidance history
Iovance Biotherapeutics (IOVA) guidance history: what it guided and what it reported
Iovance Biotherapeutics gave guidance in 10 earnings releases on file since Aug 8, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.0% against the guided midpoint. Its releases raised guidance once and lowered it once.
Revenue
Met or beat 2 of 2 periods (1 above, 1 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $350M–$370M (Aug 6, 2026) → raised $410M–$420M (Sep 29, 2026) → reaffirmed $410M–$420M (Nov 5, 2026) | — | to be reported | — |
| Q2 2026 | $86.0M–$88.0M (May 7, 2026) | $99.3M | above the range | +14.2% |
| FY2025 | $300M (Feb 27, 2025) | $264M | met | -12.2% |
Gross margin
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2024 | 70.0% (Nov 7, 2024) | — | — | — |
| FY2025 | 70.0% (Aug 8, 2024) → reaffirmed 70.0% (Feb 27, 2025) → lowered 60.9% (Aug 7, 2025) | — | — | — |
The latest quarter
Iovance Biotherapeutics, Q3 2026: revenue $121M (+80% year over year), operating margin -19.7%, net loss $22.3M, operating cash flow −$4.5M. The chart follows the revenue to costs, profit and cash.
Questions
Does Iovance Biotherapeutics beat its guidance?
Iovance Biotherapeutics gave guidance in 10 earnings releases on file since Aug 8, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.0% against the guided midpoint.
How often does Iovance Biotherapeutics raise guidance?
Its earnings releases raised guidance once and lowered it once since Aug 8, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.